By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


 

Zeltia Group 

Calle Jose Abascal 2

Madrid    28003  Spain
Phone: 91-444-4500 Fax: 91-593-2954


SEARCH JOBS


Industry
Biotechnology






Company News
Johnson & Johnson (JNJ) Withdraws Cancer Drug Petition; Zeltia Group (18494051.MA) to Miss $10 Million Yondelis Payment After U.S. Setback 5/2/2011 7:13:58 AM
Zeltia Group (18494051.MA) Fails to Win U.K. Backing for Ovarian Cancer Drug 3/11/2011 6:33:17 AM
74 Percent EBITDA Improvement at Zeltia Group (18494051.MA) in 2010 2/25/2011 9:17:41 AM
Australian Regulator Rejects Zeltia Group (18494051.MA)'s Cancer Drug Yondelis 11/12/2010 6:59:01 AM
Zeltia Group (18494051.MA): Yondelis(R) Sales Expanded by 70 Percent 10/29/2010 7:03:53 AM
Zeltia Group (18494051.MA) Reports Positive EBITDA in First Half of 2010 7/29/2010 11:53:18 AM
Zeltia Group (18494051.MA) Achieves Consolidated EBITDA Break-Even in 1Q10 4/30/2010 12:47:00 PM
Zeltia Group (18494051.MA) Achieves Consolidated EBITDA Break-Even in 1Q10 4/30/2010 10:20:34 AM
Zeltia Group (18494051.MA) Revenues up 53.3% 2/26/2010 6:57:02 AM
EU Agency Backs Zeltia Group (18494051.MA) Drug for Ovarian Cancer 9/25/2009 6:52:19 AM
1234
//-->